Matthijs D. Kruizinga

Author

Also Known As

Kruizinga, M.D., M KRUIZINGA, M. D. Kruizinga, M.D. Kruizinga, Matthijs D Kruizinga, Matthijs D. Kruizinga, Matthijs Kruizinga

Publications

616

Citations

H-Index

Concepts

All Affiliations

Haga Hospital Centre for Human Drug Research Leiden University Medical Center Maastricht University Medical Centre Juliana Kinderziekenhuis

About

Matthijs D. Kruizinga is an author at Haga Hospital specializing in medicine, pediatrics, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	43
2	Health Sciences	1	1	18
3	Public Health	1	1	12
4	Social Sciences	1	1	13
5	Health Studies	1	1	18

Matthijs D. Kruizinga

Publications

278

Citations

H-Index

Page 1

	Year	Citations
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Matthijs D. Kruizinga, Maarten J. D. van Tol, Vincent Bekker, Biology of Blood and Marrow Transplantation	2017	74
Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis Matthijs D. Kruizinga, Esmée Essers, Frederik E. Stuurman, Pediatric Pulmonology	2020	33
Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children Matthijs D. Kruizinga, N. van der Heide, Allison C. Moll, PLoS ONE	2021	22
Development and technical validation of a smartphone‐based pediatric cough detection algorithm Matthijs D. Kruizinga, Ahnjili Zhuparris, Eva Dessing, Pediatric Pulmonology	2021	22
Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis Matthijs D. Kruizinga, Willem Birkhoff, Michiel J. van Esdonk, British Journal of Clinical Pharmacology	2019	20
Effect of INTELLiVENT-ASV versus Conventional Ventilation on Ventilation Intensity in Patients with COVID-19 ARDS—An Observational Study Laura A. Buiteman‐Kruizinga, Hassan E. Mkadmi, Ary Serpa Neto, Journal of Clinical Medicine	2021	20
Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care Matthijs D. Kruizinga, Esmée Essers, Frederik E. Stuurman, European Respiratory Journal AsthmaPhysical ActivityPulmonary CareWearable TechnologyPediatric Lung Disease	2021	18
Effect of lockdowns on the epidemiology of pediatric respiratory disease—A retrospective analysis of the 2021 summer epidemic Matthijs D. Kruizinga, Jeroen G. Noordzij, Marlies A. van Houten, Pediatric Pulmonology	2023	18
Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study Amadou Samb, Matthijs D. Kruizinga, Younes Tallahi, British Journal of Clinical Pharmacology	2021	16
Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B Matthijs D. Kruizinga, Rob Zuiker, Elif Sali, Neurotherapeutics Genetic TestingGeneticsMotor DevelopmentGenetic EpidemiologyDisability	2020	13

Page 1